A DOT urine test is a federally mandated drug screening required for employees in safety-sensitive transportation jobs. It follows strict rules set by the U.S. Department of Transportation under 49 CFR Part 40, and it screens for five categories of drugs using a urine sample collected under tight chain-of-custody procedures. If you drive a commercial truck, operate a bus, work on a pipeline, fly aircraft, or hold other safety-sensitive transportation roles, this is the drug test that applies to you.
Who Has to Take It
Congress passed the Omnibus Transportation Employee Testing Act in 1991, recognizing the need for a drug- and alcohol-free transportation industry. The law requires DOT agencies to implement drug and alcohol testing for safety-sensitive employees. The most common group affected is commercial motor vehicle drivers who hold a commercial driver’s license (CDL), but the requirement also covers pilots, railroad workers, transit operators, merchant mariners, and pipeline workers.
The testing program is not optional for employers or employees in these roles. It is a condition of performing safety-sensitive work, and the rules are uniform across the country regardless of state-level marijuana laws or employer preferences.
What Drugs It Screens For
The DOT test is a standardized 5-panel drug screen. It checks for:
- Marijuana (THC)
- Cocaine
- Amphetamines, including methamphetamine, MDMA (ecstasy), and MDA
- Opioids, including codeine, morphine, heroin (detected as 6-AM), hydrocodone, hydromorphone, oxycodone, and oxymorphone
- Phencyclidine (PCP)
The opioid category was expanded in January 2018 to include semi-synthetic prescription opioids like oxycodone and hydrocodone, which were not part of the original panel. This means a positive result can come from prescription painkillers, not just illegal drugs. If you have a legitimate prescription, that gets addressed later in the process by a medical review officer.
When You’ll Be Tested
There are six specific circumstances that trigger a DOT drug test:
- Pre-employment: You must produce a negative drug test result before you can operate a commercial vehicle or perform other safety-sensitive work. This is a drug-only test (no alcohol).
- Post-accident: After a qualifying accident involving a commercial vehicle on a public road, surviving drivers must be tested for both drugs and alcohol.
- Random testing: Employers must randomly test at least 25% of their driver pool for drugs and 10% for alcohol each calendar year. You can be selected at any time with no advance notice.
- Reasonable suspicion: If a trained supervisor observes specific signs of impairment, such as changes in your appearance, behavior, speech, or body odor, the employer can require an immediate test.
- Return-to-duty: After a drug or alcohol violation, you must pass a test before resuming safety-sensitive work.
- Follow-up: After returning to duty, you’ll face additional unannounced tests over a prescribed period.
How the Collection Works
The urine collection process is more controlled than a standard workplace drug test. Every DOT collection is a split specimen collection, meaning your sample gets divided into two bottles at the collection site. The collector (not you) pours at least 30 mL into the primary specimen bottle and at least 15 mL into a second bottle. The second bottle is your backup: if the primary specimen tests positive, you have the right to request that the split specimen be tested at a different laboratory.
After filling both bottles, the collector seals them with tamper-evident seals, writes the date on the seals, and asks you to initial them to confirm those are your specimens. The entire process happens in your presence. A chain-of-custody form tracks the sample from the moment you provide it through lab analysis and reporting. Any urine left in the collection container is discarded.
You’ll typically be asked to empty your pockets before providing the sample, and the collector may inspect the collection area. In certain situations, such as a return-to-duty test or if a previous sample appeared tampered with, the collection may be directly observed.
What Happens at the Lab
DOT specimens go to laboratories certified by the Department of Health and Human Services. The lab runs an initial screening test first, using established cutoff levels to filter out trace amounts that don’t indicate drug use. For marijuana, the initial screening cutoff is 50 ng/mL. For cocaine, it’s 150 ng/mL. For amphetamines, 500 ng/mL.
If a sample tests above the initial cutoff, the lab runs a more precise confirmatory test with lower thresholds. Marijuana confirmation drops to 15 ng/mL, cocaine to 100 ng/mL, and amphetamines to 250 ng/mL. A sample must test positive at both stages before it’s reported as a lab-confirmed positive. This two-step approach reduces false positives from foods, supplements, or environmental exposure.
The Medical Review Officer’s Role
A lab-confirmed positive result does not go straight to your employer. It first goes to a Medical Review Officer (MRO), a licensed physician trained and certified to interpret drug test results. The MRO’s job is to determine whether there is a legitimate medical explanation for the positive result.
The MRO will contact you for a confidential interview. If you have a valid prescription for a medication that caused the positive (say, a prescribed opioid painkiller or an amphetamine-based ADHD medication), the MRO can verify that prescription and report the result to your employer as negative. If there’s no legitimate explanation, the MRO verifies the result as positive and reports it to your employer’s designated representative. The MRO also reviews results flagged as adulterated or substituted, meaning the lab detected evidence that the specimen was tampered with or isn’t consistent with normal human urine.
What Counts as Refusing to Test
Refusing a DOT drug test carries the same consequences as a positive result, and the definition of “refusal” is broad. You don’t have to explicitly say no. Any of the following counts as a refusal:
- Leaving the testing site before the process is complete
- Failing to provide a specimen
- Not allowing observation during a directly observed collection
- Failing to provide enough urine when no medical explanation exists
- Refusing to empty your pockets, wash your hands, or cooperate with any part of the process
- Possessing or wearing a prosthetic device that could interfere with collection
- Admitting to the collector or MRO that you tampered with the specimen
A refusal is recorded and reported through the same channels as a verified positive, and it triggers the same consequences and return-to-duty requirements.
What Happens After a Positive Result
A verified positive test or a refusal immediately removes you from safety-sensitive duties. You cannot drive a commercial vehicle, fly, or perform any other covered work until you complete the return-to-duty process. That process has several required steps.
First, you must be evaluated by a Substance Abuse Professional (SAP), a qualified counselor or clinician who assesses your situation and recommends a course of education or treatment. This could range from a drug education program to inpatient treatment, depending on the SAP’s assessment. After you complete whatever program the SAP recommended, the SAP re-evaluates you to confirm compliance and creates a follow-up testing plan.
Only after the SAP determines you’re eligible can your employer send you for a return-to-duty drug test. You need a negative result on that test before you can resume safety-sensitive work. Once you’re back on the job, your employer must carry out the follow-up testing plan the SAP established, which means additional unannounced tests over a set period. Any employer you work for during that period is required to continue the follow-up testing schedule.
Oral Fluid Testing as a New Option
In November 2024, the DOT finalized a rule allowing oral fluid (saliva) testing as an alternative to urine testing. The rule took effect in December 2024, but there’s a practical catch: oral fluid testing cannot actually begin in DOT programs until the Department of Health and Human Services certifies at least one laboratory to process oral fluid specimens. As of now, that certification hasn’t happened yet, so urine remains the only collection method in use for DOT testing. Once a lab is certified, employers will have the option to use either urine or oral fluid for their testing programs.